跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TALTZ ixekizumab 80 mg/mL solution for injection prefilled pen - TGA Drug Approval Details
Approvals
/
TGA
/
TALTZ ixekizumab 80 mg/mL solution for injection prefilled pen
Approved
STANDARD
TALTZ ixekizumab 80 mg/mL solution for injection prefilled pen
Eli Lilly Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
7de9f8e3d5bc3fbf
Company
Eli Lilly Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7de9f8e3d5bc3fbf
Product Name
TALTZ ixekizumab 80 mg/mL solution for injection prefilled pen
Artg Id
253893
Artg Name
TALTZ ixekizumab 80 mg/mL solution for injection prefilled pen
Sponsor
Eli Lilly Australia Pty Ltd
Company Detail Path
/organization/eli-lilly-australia-pty-ltd
Artg Date
2016-09-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d0f87988e0b78205a115f23be8583344.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f7dbd2e274cd26e23b25dc51659a07b0.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
7de9f8e3d5bc3fbf
Type
Standard
Back to TGA Approvals